News

Stop TB Partnership Craig David Video Series #3

In a newly released clip – the third in a series of videos shot in South Africa during his first country visit as a Goodwill Ambassador against Tuberculosis – British R&B star Craig David talks with Dr Sizulu Moyo, a tuberculosis researcher at Stellenbosch University.

Dr Sizulu Moyo

Dr Sizulu Moyo

Against the backdrop of a busy research laboratory, Craig learns that lots of progress has been made and momentum gained in the diagnosis and treatment of tuberculosis thanks to collaboration among partners as well as increased awareness and commitment from poor and rich countries alike, spurred by the link between tuberculosis and HIV/AIDS: tuberculosis is the leading infectious killer of people living with HIV.

Two key challenges mentioned by Dr Moyo are the need for sufficient funding to develop an effective vaccine and the need for tuberculosis patients to complete their course of treatment (which lasts 6 months or more) to keep the medicines effective: incomplete treatment will lead to the tuberculosis bacteria becoming drug-resistant. While people are aware that they should finish treatment, she explains, “it’s a complicated scenario; there are many things that come into play…We need understand where they are coming from. They are people with lives, with families.”

Despite her laboratory surroundings Dr Moyo remains very aware of the real-life implications of her research: “It’s not only about the documents that you read, any nice brochures, it’s not about the presentations that you make… TB affects real people, real families and real communities.”

More News
23 Aug 2022
Last week, the PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings...
4 May 2022
Earlier this week, the World Health Organization (WHO) released a rapid communication which detailed the upcoming changes to the treatment guidance for drug-resistant tuberculosis (DR-TB). These guidelines are used to inform national TB programmes globally on how to treat patients with these...
5 Apr 2022
On April 01, 2022, the Stop TB Partnership launched the second online consultation for the new Global Plan to End TB 2023-2030. Over the years, the Global Plans have been important tools for advocacy and resource mobilization, and served as a reference document for donors and stakeholders. In May...